BR9812699A - Benzamidine derivatives - Google Patents
Benzamidine derivativesInfo
- Publication number
- BR9812699A BR9812699A BR9812699-7A BR9812699A BR9812699A BR 9812699 A BR9812699 A BR 9812699A BR 9812699 A BR9812699 A BR 9812699A BR 9812699 A BR9812699 A BR 9812699A
- Authority
- BR
- Brazil
- Prior art keywords
- benzamidine derivatives
- benzamidine
- derivatives
- prophylaxis
- inhibitors
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D271/00—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms
- C07D271/02—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms not condensed with other rings
- C07D271/06—1,2,4-Oxadiazoles; Hydrogenated 1,2,4-oxadiazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D271/00—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms
- C07D271/02—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms not condensed with other rings
- C07D271/06—1,2,4-Oxadiazoles; Hydrogenated 1,2,4-oxadiazoles
- C07D271/07—1,2,4-Oxadiazoles; Hydrogenated 1,2,4-oxadiazoles with oxygen, sulfur or nitrogen atoms, directly attached to ring carbon atoms, the nitrogen atoms not forming part of a nitro radical
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
- C07D295/18—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carboxylic acids, or sulfur or nitrogen analogues thereof
- C07D295/182—Radicals derived from carboxylic acids
- C07D295/192—Radicals derived from carboxylic acids from aromatic carboxylic acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/22—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with hetero atoms directly attached to ring nitrogen atoms
- C07D295/26—Sulfur atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Vascular Medicine (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Diabetes (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Furan Compounds (AREA)
- Pyridine Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Pyrane Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Heterocyclic Compounds Containing Sulfur Atoms (AREA)
- Quinoline Compounds (AREA)
- Hydrogenated Pyridines (AREA)
Abstract
Patente de Invenção: <B>"DERIVADOS DE BENZAMIDINA"<D>. Novos compostos de fórmula I em que X, Y, R^ 1^, R^ 2^ e R^ 3^ são como definidos na reivindicação 1 de patente, são inibidores de fator de coagulação Xa e podem ser empregados para a profilaxia e/ou terapia de distúrbios tromboembólicos.Invention Patent: <B> "BENZAMIDINE DERIVATIVES" <D>. New compounds of formula I in which X, Y, R ^ 1 ^, R ^ 2 ^ and R ^ 3 ^ are as defined in patent claim 1, are inhibitors of coagulation factor Xa and can be used for prophylaxis and / or therapy for thromboembolic disorders.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19743435A DE19743435A1 (en) | 1997-10-01 | 1997-10-01 | Benzamidine derivatives |
PCT/EP1998/005898 WO1999016751A1 (en) | 1997-10-01 | 1998-09-16 | Benzamidine derivatives as factor xa inhibitors |
Publications (1)
Publication Number | Publication Date |
---|---|
BR9812699A true BR9812699A (en) | 2000-08-22 |
Family
ID=7844313
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR9812699-7A BR9812699A (en) | 1997-10-01 | 1998-09-16 | Benzamidine derivatives |
Country Status (19)
Country | Link |
---|---|
US (1) | US6492368B1 (en) |
EP (1) | EP1025086B1 (en) |
JP (1) | JP2001518467A (en) |
KR (1) | KR20010024386A (en) |
CN (1) | CN1272107A (en) |
AR (1) | AR017164A1 (en) |
AT (1) | ATE243681T1 (en) |
AU (1) | AU736080B2 (en) |
BR (1) | BR9812699A (en) |
CA (1) | CA2305568A1 (en) |
DE (2) | DE19743435A1 (en) |
HU (1) | HUP0004306A3 (en) |
ID (1) | ID24430A (en) |
NO (1) | NO20001687L (en) |
PL (1) | PL339173A1 (en) |
RU (1) | RU2194044C2 (en) |
SK (1) | SK282799B6 (en) |
WO (1) | WO1999016751A1 (en) |
ZA (1) | ZA988937B (en) |
Families Citing this family (51)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20010015639A (en) | 1997-09-30 | 2001-02-26 | 스즈키 다다시 | Sulfonyl derivatives |
CA2331042A1 (en) * | 1998-05-02 | 1999-11-11 | Astrazeneca Ab | Heterocyclic derivatives which inhibit factor xa |
GB9809349D0 (en) | 1998-05-02 | 1998-07-01 | Zeneca Ltd | Heterocyclic derivatives |
CA2340100A1 (en) * | 1998-08-11 | 2000-02-24 | Daiichi Pharmaceutical Co., Ltd. | Novel sulfonyl derivatives |
EP1088821A1 (en) * | 1999-09-28 | 2001-04-04 | Applied Research Systems ARS Holding N.V. | Pharmaceutically active sulfonamide derivatives |
EP1829535A3 (en) * | 1999-10-27 | 2007-10-24 | Tanox, Inc. | Tissue factor antagonists and methods of use thereof |
CN1390122A (en) * | 1999-10-27 | 2003-01-08 | 苏诺尔分子公司 | Tissue factor antagonists and methods of use thereof |
DE10035927A1 (en) | 2000-07-21 | 2002-03-07 | Asta Medica Ag | New heteroaryl derivatives and their use as medicines |
DE10035928A1 (en) | 2000-07-21 | 2002-03-07 | Asta Medica Ag | New heteroaryl derivatives and their use as medicines |
EP1193268A1 (en) * | 2000-09-27 | 2002-04-03 | Applied Research Systems ARS Holding N.V. | Pharmaceutically active sulfonamide derivatives bearing both lipophilic and ionisable moieties as inhibitors of protein Junkinases |
EP1193256A1 (en) * | 2000-09-27 | 2002-04-03 | Applied Research Systems ARS Holding N.V. | Pharmaceutically active benzsulfonamide derivatives as inhibitors of JNK proteins |
EP1193267A1 (en) * | 2000-09-27 | 2002-04-03 | Applied Research Systems ARS Holding N.V. | Pharmaceutically active hydrophilic sulfonamide derivatives as inhibitors of protein JunKinases |
DE60144284D1 (en) | 2000-11-01 | 2011-05-05 | Millennium Pharm Inc | NITROGENIC HETEROCYCLIC COMPOUNDS AND METHOD FOR THE PRODUCTION THEREOF |
DE10102322A1 (en) * | 2001-01-19 | 2002-07-25 | Merck Patent Gmbh | New disubstituted and trisubstituted benzene derivatives useful as coagulation inhibitors for the treatment of thromboembolic diseases |
DE10130718A1 (en) * | 2001-06-26 | 2003-01-02 | Merck Patent Gmbh | carbohydrate derivatives |
ATE473005T1 (en) | 2002-03-13 | 2010-07-15 | Janssen Pharmaceutica Nv | HISTONE DEACETYLASE INHIBITORS |
US7205304B2 (en) | 2002-03-13 | 2007-04-17 | Janssen Pharmaceutica N.V. | Sulfonyl-Derivatives as novel inhibitors of histone deacetylase |
ES2543588T3 (en) | 2002-12-03 | 2015-08-20 | Pharmacyclics Llc | 2- (2-Hydroxybiphenyl-3-yl) -1H-benzoimidazol-5-carboxamidine derivatives as inhibitors of factor VIIa |
TW200633990A (en) | 2004-11-18 | 2006-10-01 | Takeda Pharmaceuticals Co | Amide compound |
JP5118975B2 (en) | 2004-12-24 | 2013-01-16 | アストラゼネカ・アクチエボラーグ | Heterocyclic compounds as CCR2B antagonists |
WO2007007588A1 (en) * | 2005-07-08 | 2007-01-18 | Ono Pharmaceutical Co., Ltd. | Compound having cyclic group with planarity as core |
US7825122B2 (en) * | 2005-12-14 | 2010-11-02 | Amgen Inc. | Diaza heterocyclic sulfonamide derivatives and their uses |
WO2007078335A2 (en) * | 2005-12-21 | 2007-07-12 | Decode Genetics, Ehf. | Biaryl nitrogen heterocycle inhibitors of lta4h for treating inflammation |
GB0525957D0 (en) * | 2005-12-21 | 2006-02-01 | Astrazeneca Ab | Methods |
AU2007281911B2 (en) | 2006-08-04 | 2014-02-06 | Beth Israel Deaconess Medical Center | Inhibitors of pyruvate kinase and methods of treating disease |
JO2972B1 (en) | 2007-06-08 | 2016-03-15 | جانسين فارماسوتيكا ان. في | Piperidine/Piperazine derivatives |
ES2483898T3 (en) * | 2007-06-08 | 2014-08-08 | Janssen Pharmaceutica, N.V. | Piperidine / Piperazine Derivatives |
TWI426070B (en) * | 2007-06-08 | 2014-02-11 | Janssen Pharmaceutica Nv | Piperidine/piperazine derivatives |
AU2008258549B2 (en) * | 2007-06-08 | 2013-11-14 | Janssen Pharmaceutica N.V. | Piperidine/piperazine derivatives |
ES2663517T3 (en) | 2007-08-27 | 2018-04-13 | Dart Neuroscience (Cayman) Ltd | Therapeutic compounds of isoxazole |
WO2009035542A2 (en) * | 2007-09-07 | 2009-03-19 | Theravance, Inc. | Guanidine-containing compounds useful as muscarinic receptor antagonists |
AU2008301718B2 (en) * | 2007-09-21 | 2013-01-10 | Msd K.K. | 4-sulfonylpiperidine derivatives |
UY31863A (en) | 2008-06-05 | 2010-01-05 | Janssen Pharmaceutica Nv | DRUG COMBINATIONS UNDERSTANDING A DGAT INHIBITOR AND A PPAR AGONIST |
US20100152197A1 (en) * | 2008-12-15 | 2010-06-17 | Astrazeneca Ab | (4-tert-butylpiperazin-2-yl)(piperazin-1-yl)methanone-n-carboxamide derivatives |
US8575185B2 (en) * | 2009-02-26 | 2013-11-05 | Reviva Pharmaceuticals, Inc. | Compositions, synthesis, and methods of utilizing quinazolinedione derivatives |
CA2758071C (en) | 2009-04-06 | 2018-01-09 | Agios Pharmaceuticals, Inc. | Pyruvate kinase m2 modulators, therapeutic compositions and related methods of use |
EP3708169A1 (en) | 2009-06-29 | 2020-09-16 | Agios Pharmaceuticals, Inc. | 2,3-dihydrobenzo[b][1,4]dioxine-6-sulfonamide derivatives having an anticancer activity |
CA2766873C (en) | 2009-06-29 | 2018-08-21 | Agios Pharmaceuticals, Inc. | Therapeutic compositions and related methods of use |
CA2821975A1 (en) | 2010-12-17 | 2012-06-21 | Shunqi Yan | N-(4-(azetidine-1-carbonyl)phenyl)-(hetero-) arylsulfonamide derivatives as pyruvate kinase m2 pkm2 modulators |
MX336022B (en) | 2010-12-21 | 2016-01-06 | Agios Pharmaceuticals Inc | Bicyclic pkm2 activators. |
TWI549947B (en) | 2010-12-29 | 2016-09-21 | 阿吉歐斯製藥公司 | Therapeutic compounds and compositions |
HUE039269T2 (en) | 2011-05-03 | 2018-12-28 | Agios Pharmaceuticals Inc | Pyruvate kinase activators for use in therapy |
WO2012151440A1 (en) | 2011-05-03 | 2012-11-08 | Agios Pharmaceuticals, Inc. | Pyruvate kinase activators for use for increasing lifetime of the red blood cells and treating anemia |
FR2976943B1 (en) * | 2011-06-23 | 2013-07-12 | Metabolys | PIPERAZINE DERIVATIVES, PROCESSES FOR THEIR PREPARATION AND USES THEREOF IN THE TREATMENT OF INSULIN RESISTANCE |
KR102194745B1 (en) | 2013-03-13 | 2020-12-24 | 포르마 세라퓨틱스 인크. | Novel compounds and compositions for inhibition of fasn |
EP2968264A4 (en) | 2013-03-14 | 2016-11-02 | Celtaxsys Inc | Inhibitors of leukotriene a4 hydrolase |
WO2014139144A1 (en) | 2013-03-15 | 2014-09-18 | Agios Pharmaceuticals, Inc. | Therapeutic compounds and compositions |
CA2907657A1 (en) | 2013-03-21 | 2014-09-25 | Merck Patent Gmbh | Piperazine derivatives as fasn inhibitors |
RS64777B1 (en) | 2015-06-11 | 2023-11-30 | Agios Pharmaceuticals Inc | Methods of using pyruvate kinase activators |
TWI767148B (en) | 2018-10-10 | 2022-06-11 | 美商弗瑪治療公司 | Inhibiting fatty acid synthase (fasn) |
WO2020092395A1 (en) | 2018-10-29 | 2020-05-07 | Forma Therapeutics, Inc. | SOLID FORMS OF (4-(2-FLUORO-4-(1-METHYL-1 H-BENZO[d]IMIDAZOL-5-YL)BENZOYL) PIPERAZIN-1-YL)(1-HYDROXYCYCLOPROPYL)METHANONE |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH05503300A (en) | 1990-11-15 | 1993-06-03 | ペンタファルム アクチェンゲゼルシャフト | Meta-substituted phenylalanine derivatives |
ZA928276B (en) * | 1991-10-31 | 1993-05-06 | Daiichi Seiyaku Co | Aromatic amidine derivates and salts thereof. |
GB9208740D0 (en) | 1992-04-23 | 1992-06-10 | Glaxo Group Ltd | Chemical compounds |
DE4234295A1 (en) * | 1992-10-12 | 1994-04-14 | Thomae Gmbh Dr K | Carboxylic acid derivatives, medicaments containing these compounds and process for their preparation |
DE4302485A1 (en) | 1993-01-29 | 1994-08-04 | Merck Patent Gmbh | Piperazine derivatives |
CA2216796C (en) | 1995-03-30 | 2003-09-02 | Pfizer Inc. | Quinazoline derivatives |
AU6318896A (en) * | 1995-07-06 | 1997-02-05 | Japan Tobacco Inc. | Benzamidoxime derivatives and medicinal use thereof |
CA2197364A1 (en) * | 1996-02-15 | 1997-08-16 | Toshikazu Suzuki | Phenol compound and process for preparing the same |
ATE334975T1 (en) * | 1997-05-30 | 2006-08-15 | Takeda Pharmaceutical | SULFONAMIDE DERIVATIVES, THEIR PRODUCTION AND USE |
-
1997
- 1997-10-01 DE DE19743435A patent/DE19743435A1/en not_active Withdrawn
-
1998
- 1998-09-16 AT AT98948982T patent/ATE243681T1/en not_active IP Right Cessation
- 1998-09-16 RU RU2000110737/04A patent/RU2194044C2/en not_active IP Right Cessation
- 1998-09-16 CN CN98809650A patent/CN1272107A/en active Pending
- 1998-09-16 CA CA002305568A patent/CA2305568A1/en not_active Abandoned
- 1998-09-16 WO PCT/EP1998/005898 patent/WO1999016751A1/en not_active Application Discontinuation
- 1998-09-16 SK SK447-2000A patent/SK282799B6/en unknown
- 1998-09-16 HU HU0004306A patent/HUP0004306A3/en unknown
- 1998-09-16 BR BR9812699-7A patent/BR9812699A/en not_active IP Right Cessation
- 1998-09-16 PL PL98339173A patent/PL339173A1/en unknown
- 1998-09-16 ID IDW20000609A patent/ID24430A/en unknown
- 1998-09-16 AU AU95407/98A patent/AU736080B2/en not_active Ceased
- 1998-09-16 DE DE59808842T patent/DE59808842D1/en not_active Expired - Fee Related
- 1998-09-16 US US09/509,729 patent/US6492368B1/en not_active Expired - Fee Related
- 1998-09-16 EP EP98948982A patent/EP1025086B1/en not_active Expired - Lifetime
- 1998-09-16 KR KR1020007003536A patent/KR20010024386A/en not_active Application Discontinuation
- 1998-09-16 JP JP2000513837A patent/JP2001518467A/en active Pending
- 1998-09-29 AR ARP980104841A patent/AR017164A1/en not_active Application Discontinuation
- 1998-09-30 ZA ZA988937A patent/ZA988937B/en unknown
-
2000
- 2000-03-31 NO NO20001687A patent/NO20001687L/en not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
NO20001687D0 (en) | 2000-03-31 |
KR20010024386A (en) | 2001-03-26 |
HUP0004306A3 (en) | 2001-12-28 |
EP1025086B1 (en) | 2003-06-25 |
SK282799B6 (en) | 2002-12-03 |
SK4472000A3 (en) | 2000-11-07 |
NO20001687L (en) | 2000-03-31 |
CA2305568A1 (en) | 1999-04-08 |
AU736080B2 (en) | 2001-07-26 |
HUP0004306A2 (en) | 2001-11-28 |
ZA988937B (en) | 1999-03-31 |
AR017164A1 (en) | 2001-08-22 |
ATE243681T1 (en) | 2003-07-15 |
AU9540798A (en) | 1999-04-23 |
CN1272107A (en) | 2000-11-01 |
DE59808842D1 (en) | 2003-07-31 |
WO1999016751A1 (en) | 1999-04-08 |
DE19743435A1 (en) | 1999-04-08 |
EP1025086A1 (en) | 2000-08-09 |
ID24430A (en) | 2000-07-20 |
RU2194044C2 (en) | 2002-12-10 |
JP2001518467A (en) | 2001-10-16 |
US6492368B1 (en) | 2002-12-10 |
PL339173A1 (en) | 2000-12-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR9812699A (en) | Benzamidine derivatives | |
BR9813477A (en) | Benzamidine derivatives | |
BR0116804A (en) | Phenolic derivatives | |
BRPI0014076B8 (en) | benzamides and related factor xa inhibitors | |
BR0014078A (en) | Xa factor inhibitors | |
GB9801690D0 (en) | Therapeutic agents | |
BR0112292A (en) | Compound, pharmaceutical composition, method for treating or preventing thromboembolic disorders and use of a compound | |
BR9916111A (en) | Phenylglycine derivatives | |
BR0208192A (en) | Spirotricylic derivatives and their use as phosphodiesterase-7 inhibitors. | |
BR0116115A (en) | Carboxamide derivatives and their use in the treatment of thromboembolic diseases and tumors. | |
BR0010220A (en) | Pyrimidinone compounds | |
BRPI0411466A (en) | 1 - [(4-Ethinylphenyl)] - 2 - [(phenyl)] - pyrrolidine-1,2-dicarboxamide derivatives as inhibitors of xa and viia coagulation factors for the treatment of thrombosis | |
BRPI0408444A (en) | 1-n- (phenyl) -2-n- (phenyl) pyrazolidine-1,2-dicarboxamide derivatives as coagulation factor xa inhibitors for the treatment of thrombosis | |
DK0672659T3 (en) | Antithrombotic agents | |
BR9810520A (en) | Factor xa inhibitor alone or in combination with an anti-platelet aggregator, against arterial thrombosis | |
BR9916774A (en) | Derivatives of imidazo [4,5-c] pyridine-4-one | |
BR0008608A (en) | Pyrazole-3-one derivatives | |
WO2004002477A8 (en) | 2-(phenyl)-2h-pyrazole-3-carboxylic acid-n-4-(thioxo-heterocyclyl)-phenyl-amide derivatives and corresponding imino-heterocyclyl derivatives and relates compounds for use as inhibitors of the coagulation factors xa and/or viia for treating thromboses | |
BR9813719A (en) | Therapeutic agents | |
SE0302756D0 (en) | Novel Compounds | |
BR9910021A (en) | Biphenyl derivatives | |
BR0213680A (en) | Phenoxy-n-4- (1,1-dioxoisothiazolidin-2-yl) phenyl valeramide derivatives and other compounds as inhibitors of coagulation factor xa for the treatment of thromboembolic diseases and tumors | |
BR9912307A (en) | Fkbp inhibitors | |
BR0211737A (en) | Phenolic derivatives as xa factor inhibitors | |
WO2002006280A3 (en) | INHIBITORS OF FACTOR Xa |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 6O,7O,8O E 9O ANUIDADES |
|
B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 1909 DE 07/08/2007. |